Paper · 2018 · Open access

Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.

Europe PMC (PubMed Central), 18(5), 1–141 · Published 1 January 2018

Open full textCite this paper

In brief

“Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.” is a 2018 paper, published in Europe PMC (PubMed Central). OpenAlex counts 35 citations as of 20 November 2026, which puts it in the top 8% of works published in 2018 by citations. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
35
Most cited in
2020 (12)
Field-weighted impact
2.58
References
97

Abstract

BACKGROUND: Cognitive behavioural therapy (CBT) for psychosis is a distinct type of psychotherapy that has been recommended together with antipsychotic drugs and comprehensive usual care in the management of schizophrenia, a complex mental health disorder associated with a high economic and societal burden. The objectives of this report were to assess the effectiveness, harms, cost-effectiveness, and lived experience of CBT for psychosis in improving outcomes for adults with a primary diagnosis of schizophrenia. METHODS: We performed literature searches on March 28 and April 5, 2017, and undertook a qualitative synthesis of systematic reviews of the clinical and economic literature comparing CBT for psychosis with any comparator interventions (e.g., usual care, waitlist control, or pharmacotherapy) in adults with a diagnosis of schizophrenia as defined by any criteria (including related disorders such as schizoaffective disorder).We developed an individual-level state-transition probabilistic model for a hypothetical cohort of adults aged 18 years and older starting with first-episode psychosis. We compared three strategies: usual care, CBT for psychosis by physicians, and CBT for psychosis by regulated nonphysician therapists. The CBT was provided in person together with usual care including pharmacotherapy: 16 structured sessions (individual or group) for first-episode psychosis and 24 individual sessions for relapse or treatment-resistant disease. We calculated incremental cost-effectiveness ratios (ICERs) over 5 years using the Ontario Ministry of Health and Long-Term Care perspective and a discount rate of 1.5%. We also estimated the 5-year budget impact of publicly funding CBT for psychosis in Ontario.In addition, we interviewed 13 people with lived experience of schizophrenia and psychosis about their values and preferences surrounding CBT and other treatments. RESULTS: < .05) and negative symptoms (e.g., blunt affect) (SMD -0.32, 95% CI -0.59 to -0.04) at end of treatment. No significant differences were observed for social function, distress associated with psychosis, relapse, or quality of life.Compared with any control, CBT for psychosis significantly improved overall psychotic symptoms, positive symptoms, auditory hallucinations, delusions, and negative symptoms. Compared with other forms of therapy, CBT for psychosis showed inconsistent results at end of treatment for overall psychotic symptoms, positive symptoms, auditory hallucinations, and delusions. In people with first-episode psychosis, CBT for psychosis was not significantly more effective for the prevention of relapse when compared with other forms of therapy or usual care (odds ratio [OR] 1.11, 95% CI 0.63-1.95 and OR 1.15, 95% CI 0.65-2.04, respectively).Low-intensity CBT for psychosis (fewer than 16 face-to-face sessions) compared with any type of treatment significantly improved overall psychotic symptoms and social function at follow-up (SMD -0.40, 95% CI -0.74 to -0.06…

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment. (2018). Europe PMC (PubMed Central), 18(5), 1–141. http://europepmc.org/pmc/articles/PMC6235075

MLA 9

“Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.” Europe PMC (PubMed Central), vol. 18, no. 5, 2018, pp. 1–141. http://europepmc.org/pmc/articles/PMC6235075.

Chicago

2018. “Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.” Europe PMC (PubMed Central) 18 (5): 1–141. http://europepmc.org/pmc/articles/PMC6235075.

Harvard

(2018) ‘Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.’, Europe PMC (PubMed Central), 18(5), pp. 1–141. Available at: http://europepmc.org/pmc/articles/PMC6235075.

IEEE

“Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.,” Europe PMC (PubMed Central), vol. 18, no. 5, pp. 1–141, 2018.

BibTeX

@article{anon2018cognitive,
  title     = {{Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment.}},
  journal   = {Europe PMC (PubMed Central)},
  year      = {2018},
  volume    = {18},
  number    = {5},
  pages     = {1--141},
  url       = {http://europepmc.org/pmc/articles/PMC6235075}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20201212
202144
202244
202322
202422
202599
202622

Its field-weighted citation impact is 2.58: it has been cited 2.58 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • cognitive behavioural therapy for psychosis
  • schizophrenia
  • first-episode psychosis
  • relapse prevention
  • treatment-resistant psychosis
  • cost-effectiveness
  • budget impact
  • state transition model

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Cognitive Behavioural Therapy for Psychosis: A Health Technology Assessment. (2018). Europe PMC (PubMed Central), 18(5), 1–141. http://europepmc.org/pmc/articles/PMC6235075

How many times has this paper been cited?

35 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.